Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Cat Vaccines Market

Cat Vaccines Market Share

Report ID: GMI12323
Published Date: Nov 2024
Report Format: PDF

Download Free Sample

Cat Vaccines Market Share

The market is highly competitive, with prominent players like Merck, Zoetis, Boehringer Ingelheim, and Elanco leading the industry. Key market strategies include expanding product portfolios, with a focus on innovative formulations such as combined vaccines, which provide protection against multiple diseases with a single dose, and vaccines offering extended immunity durations. Additionally, emerging markets with growing awareness of pet healthcare are becoming key areas for expansion.

Cat Vaccines Market Companies

Few of the prominent players operating in the cat vaccines industry include:

Bioveta
Boehringer Ingelheim
Durvet
Elanco
Indian Immunologicals
INTAS Animal Health
Merck
Spectra
Virbac
Zoetis

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global cat vaccines industry was valued at USD 1.1 billion in 2024 and is estimated to grow at a 9.2% CAGR from 2025 to 2034, driven by increasing awareness of animal healthcare and rising pet ownership worldwide.

The modified/attenuated live segment accounted for a 50.5% market share in 2024 due to its high efficacy, robust immune response, and cost-effectiveness, making it a top choice for veterinarians and pet owners.

The U.S. cat vaccines market was valued at USD 378.7 million in 2024, supported by a large pet-owning population and a strong veterinary infrastructure.

Key players in the industry include Bioveta, Boehringer Ingelheim, Durvet, Elanco, Indian Immunologicals, INTAS Animal Health, Merck, Spectra, Virbac, and Zoetis.